Immunotherapy for Bone and Soft Tissue Sarcomas release_zmrjebklpvaajkr5ybz7vrq5oq

by Takenori Uehara, Tomohiro Fujiwara, Ken Takeda, Toshiyuki Kunisada, Toshifumi Ozaki, Heiichiro Udono

Published in BioMed Research International by Hindawi Limited.

Volume 2015p1-11 (2015)

Abstract

Although multimodal therapies including surgery, chemotherapy, and radiotherapy have improved clinical outcomes of patients with bone and soft tissue sarcomas, the prognosis of patients has plateaued over these 20 years. Immunotherapies have shown the effectiveness for several types of advanced tumors. Immunotherapies, such as cytokine therapies, vaccinations, and adoptive cell transfers, have also been investigated for bone and soft tissue sarcomas. Cytokine therapies with interleukin-2 or interferons have limited efficacy because of their cytotoxicities. Liposomal muramyl tripeptide phosphatidylethanolamine (L-MTP-PE), an activator of the innate immune system, has been approved as adjuvant therapeutics in combination with conventional chemotherapy in Europe, which has improved the 5-year overall survival of patients. Vaccinations and transfer of T cells transduced to express chimeric antigen receptors have shown some efficacy for sarcomas. Ipilimumab and nivolumab are monoclonal antibodies designed to inhibit immune checkpoint mechanisms. These antibodies have recently been shown to be effective for patients with melanoma and also investigated for patients with sarcomas. In this review, we provide an overview of various trials of immunotherapies for bone and soft tissue sarcomas, and discuss their potential as adjuvant therapies in combination with conventional therapies.
In application/xml+jats format

Archived Files and Locations

application/pdf  645.5 kB
file_mpbqo5kk5jekrbt5kct7uzoc2y
pdfs.semanticscholar.org (aggregator)
web.archive.org (webarchive)
application/pdf  1.4 MB
file_mkrnuyrbz5d2hb6drlhxhqgrv4
downloads.hindawi.com (publisher)
web.archive.org (webarchive)
web.archive.org (webarchive)
Read Archived PDF
Archived
Type  article-journal
Stage   published
Year   2015
Language   en ?
DOI  10.1155/2015/820813
PubMed  26167500
PMC  PMC4488089
Wikidata  Q28088363
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registery
ISSN-L:  2314-6133
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: b65cfc4d-0f67-4233-9d93-5c80808de730
API URL: JSON